CD8A and neoplasm: L-arginine supplementation has been shown to facilitate the metabolic shift from glycolysis to OXPHOS, enhancing T-cell survival and boosting antitumor responses of CD8+ tumor infiltrating lymphocytes (TILs).93 Notably, the functional differences resulting from TAM polarization partially depend on arginine metabolism.